Pharmacy Meets Cardiovascular Pharmacotherapy - An Update on Metabolic Syndrome
22nd & 23rd March 2024 / Salzburg, Austria
It is our pleasure to announce that registrations are open to our next in-person congress titled “Pharmacy Meets Cardiovascular Pharmacotherapy- An Update on Metabolic Syndrome”. This 2-day congress will take place on 22nd and 23rd March 2024 in Salzburg, Austria and it organised jointly by VIVIT (Vorarlberg Institute for Vascular Investigation and Treatment), PMU Salzburg University and ISCP.
The programme will offer a mix of English and German speaking lectures and presentations, and will focus on various highly relevant and interesting topics, such as happiness and cardiovascular disease, how to publish in cardiovascular pharmacotherapy; diabetes mellitus; anticoagulation; hypertension; omega-3-fatty acids; mechanisms of SGLT2-inhibition; drug treatment of LDL-cholesterol; congestive heart failure; polypharmacy; GLP1-RA in diabetes and obesity; the present and the future of the European Medicines Agency, amongst others.
For more information on the preliminary programme and for registration, please follow this link to complete the form and apply. >>https://registration.maw.co.at/kardiopharm24
A-Z of CV Pharmacotherapy:
ISCP Webinar Series
Our first five webinars produced in collaboration with our partners Radcliffe Cardiology are now available to view in the Webinars On Demand section:
1- Ferric Carboxymaltose: Ironing Out the Issues Around Heart Failure-Related Readmissions,
2- Inclisiran: A Jab Goes a Long Way,
3- Edoxaban: ENGAGEing in Individualisation of DOACs,
4- Valsartan Sacubitril: Has our PARADIGM shifted?,
5- Clopidogrel or Ticagrelor: Why, When, for Whom?, and
Details of future webinars will become available in Upcoming webinars very soon, including the next series of our own A to Z of CV Pharmacotherapy programme
Have you watched one or more of the above sessions? We value your opinion. Take 3 minutes to give us feedback on the series.
Upcoming Events
22
Mar
30
Aug
ESC 2024 LONDON
Conferences 30 Aug 2024
31
Oct
ISCP 2024 BRAZIL
Annual Meeting 31 Oct 2024
Highlights
The latest reviews, resources and expert analysis from our website.
newsfeed
Time-restricted eating tied to increased risk for death from heart disease
Posted on March 18, 2024
A time-restricted eating window of less than 8 hours was associated with increased risk for cardiovascular death, according to study findings presented... more
FDA grants breakthrough device designation for resorbable magnesium scaffold for CLTI
Posted on March 18, 2024
Biotronik announced it was granted breakthrough device designation from the FDA its below-the-knee resorbable magnesium scaffold for the treatment of chronic limb-threatening... more
Aldosterone: The hidden hormone linking hypertension and obesity, and a potential target
Posted on March 18, 2024
An op-ed published in February by Tom Frieden, MD, MPH, former director of the CDC, described hypertension as “the deadliest but most... more
Patients with higher apolipoprotein A-I levels at greater risk for giant cell arteritis
Posted on March 18, 2024
Patients who eventually developed giant cell arteritis demonstrated significantly higher levels of apolipoprotein A-I at baseline, according to population-based data published in... more
ISCP book series
Current Cardiovascular Therapy
Kaski, Juan Carlos.
Series Editor: Juan Carlos Kaski Cardiovascular pharmacotherapy is a fast-moving and complex discipline within cardiology in general. New studies, trials and indications are appearing on a regular basis. This series created with the support of the International Society of Cardiovascular Pharmacotherapy (ISCP) is designed to establish the baseline level of knowledge that a cardiovascular professional needs to know on a day-to-day basis. The information within is designed to allow readers to learn quickly and with certainty the mode of action,...
-
Antiplatelet and Anticoagulation Therapy
A. Ferro, D.A. Garcia (Eds.)
-
Pharmacological Treatment of Acute Coronary Syndromes
Avanzas, Pablo; Clemmensen, Peter(Eds.)
-
Atrial Fibrillation Therapy
Gheorghe-Andrei Dan, Antoni Bayes de Luna, John Camm(Eds.)
board of directors
Providing a leadership and advocacy role amongst members of their national societies.
 
-
Heinz Drexel
Director
Scientific Advisor & Head of VIVIT-Research Institute, Academic Teaching Hospital Feldkirch (ATHF), A - 1976 Medical degree with highest award of the Republic of Austria, University of Innsbruck 1983-1987 - Ass. Prof., leading physician of the Diabetes inpatient and outpatient clinic, University of Innsbruck - 1988-1990 Ass. Prof. of... more
-
Alberto Lorenzatti
President
Dr. Alberto J. Lorenzatti is currently the Co-Director of the DAMIC Medical Institute / Rusculleda Foundation for Research, Teaching and Patient Care (Head of the Clinical Research network with more than 30 research sites in Argentina) and he was the Chief of Cardiology at the Cordoba Hospital, Cordoba, Argentina... more
-
Pablo Avanzas
Secretary
Professor Pablo Avanzas is Director of Invasive Cardiology at Hospital Universitario Central de Asturias and Full Professor of Cardiology at University of Oviedo in Asturias, Spain. Affiliations/Memberships • Full Professor of Cardiology, University of Oviedo, Oviedo, Spain. • Director of Invasive Cardiology at Hospital Universitario Central de Asturias, Oviedo,... more
-
Sang Hong Baek
Past President
Professor Sang Hong Baek is Director of Heart Failure and Transplantation Programme and Preventive Cardiology at Seoul St. Mary's (more…) more